Safety of Ozempic for Type II Diabetes

Details

Files

Project Status:

Completed

Project Line:

Health Technology Review

Project Sub Line:

Observational Study

Project Number:

OS0005-000

The objective of this query is to determine whether there are potential safety signals among adults with type 2 diabetes mellitus newly treated with Ozempic relative to similar patients newly treated with sitagliptin. This query attempts to replicate the US FDA Sentinel’s tree-based scan statistic (TreeScan), based on potential safety signal identification analysis, using the Canadian Network for Observational Drug Effect Studies (CNODES) adaptation of the Sentinel Common Data Model to identify potential postmarket safety signals for Ozempic in Canada.

Files

Final Report View PDF

Summary Report View PDF

Last Updated : September 6, 2024